Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2016. HIV Surveillance Supplemental Report 2019;24(No. 1). 2019. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html.
Centers for Disease Control and Prevention. HIV Surveillance Report, 2018 (Preliminary); vol. 30. 2019. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html.
Centers for Disease Control and Prevention National Center for HIV/AIDS VH, and TB Prevention, Divisision of HIV/AIDS Prevention. HIV in the United States and Dependent Areas. 2019. https://www.cdc.gov/hiv/pdf/statistics/overview/cdc-hiv-us-ataglance.pdf.
Hess KL, Hu X, Lansky A, Mermin J, Hall HI. Lifetime risk of a diagnosis of HIV infection in the United States. Ann Epidemiol. 2017;27(4):238–43.
New York City Department of Health and Mental Hygiene. New York City HIV/AIDS Annual Surveillance Statistics 2017. 2019. https://www1.nyc.gov/assets/doh/downloads/pdf/ah/surveillance2017-table-all.pdf.
Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22.
Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006–2017. Am J Public Health. 2019;2018:11–8.
Poteat T, Reisner SL, Radix A. HIV epidemics among transgender women. Curr Opin HIV AIDS. 2014;9(2):168–73.
Caceres CF, Borquez A, Klausner JD, Baggaley R, Beyrer C. Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection: progress and emerging issues in research and policy. J Int AIDS Soc. 2016;19(Suppl 6):21108.
Cohen SE, Vittinghoff E, Bacon O, et al. High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project. J Acquir Immune Defic Syndr. 2015;68(4):439–48.
Haberer JE, Bangsberg DR, Baeten JM, et al. Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. AIDS. 2015;29(11):1277–85.
Jenness SM, Maloney KM, Smith DK, et al. Addressing gaps in HIV preexposure prophylaxis care to reduce racial disparities in HIV incidence in the United States. Am J Epidemiol. 2019;188(4):743–52.
Mimiaga MJ, Closson EF, Kothary V, Mitty JA. Sexual partnerships and considerations for HIV antiretroviral pre-exposure prophylaxis utilization among high-risk substance using men who have sex with men. Arch Sex Behav. 2014;43(1):99–106.
Riddell JT, Cohn JA. Reaching high-risk patients for HIV preexposure prophylaxis. JAMA. 2016;316(2):211–2.
Wu H, Mendoza MC, Huang YA, Hayes T, Smith DK, Hoover KW. Uptake of HIV preexposure prophylaxis among commercially insured persons-United States, 2010–2014. Clin Infect Dis. 2017;64(2):144–9.
United States Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States 2014: a clinical practice guideline. Washington: Centers for Disease Control and Prevention, Department of Health and Human Services; 2014.
Sullivan PS, Giler RM, Mouhanna F, et al. Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012–2017. Ann Epidemiol. 2018;28(12):833–40.
Misra K, Udeagu CC. Disparities in awareness of HIV postexposure and preexposure prophylaxis among notified partners of HIV-positive individuals, New York City 2015–2017. J Acquir Immune Defic Syndr. 2017;76(2):132–40.
Siegler AJ, Mouhanna F, Giler RM, et al. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol. 2018;28(12):841–9.
Harris NS, Johnson AS, Huang YA, et al. Vital signs: status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis - United States, 2013–2018. MMWR Morb Mortal Wkly Rep. 2019;68(48):1117–23.
Kelley CF, Kahle E, Siegler A, et al. Applying a PrEP continuum of care for men who have sex with men in Atlanta. Georgia Clin Infect Dis. 2015;61(10):1590–7.
Shover CL, Shoptaw S, Javanbakht M, et al. Mind the gaps: prescription coverage and HIV incidence among patients receiving pre-exposure prophylaxis from a large federally qualified health center in Los Angeles, CA. AIDS Behav. 2019;23:2730–40.
Scott HM, Spinelli M, Vittinghoff E, et al. Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics. AIDS. 2019;33(14):2189–95.
Amico KR. Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness. Curr Opin HIV AIDS. 2012;7(6):542–8.
Serota DP, Rosenberg ES, Lockard AM, et al. Beyond the biomedical: preexposure prophylaxis failures in a cohort of young black men who have sex with men in Atlanta, Georgia. Clin Infect Dis. 2018;67(6):965–70.
Spinelli MA, Scott HM, Vittinghoff E, et al. Missed visits associated with future preexposure prophylaxis (PrEP) discontinuation among PrEP Users in a municipal primary care health network. Open Forum Infect Dis. 2019;6(4):ofz101.
Ayala G, Makofane K, Santos GM, et al. Access to basic HIV-related services and PrEP acceptability among men who have sex with men worldwide: barriers, facilitators, and implications for combination prevention. J Sex Transm Dis. 2013;2013:953123.
Koechlin FM, Fonner VA, Dalglish SL, et al. Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature. AIDS Behav. 2017;21(5):1325–35.
Sevelius JM, Deutsch MB, Grant R. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. J Int AIDS Soc. 2016;19(Suppl 6):21105.
Grant JM, Mottet LA, Tanis J, Harrison J, Herman JL, Keisling M. Injustice at every turn: a report of the National Transgender Discrimination Survey. Washington: National Gay and Lesbian Task Force and National Center for Transgender Equality; 2011.
Bauer GR, Hammond R, Travers R, Kaay M, Hohenadel KM, Boyce M. "I don't think this is theoretical; this is our lives": how erasure impacts health care for transgender people. J Assoc Nurses AIDS Care. 2009;20(5):348–61.
Khalili J, Leung LB, Diamant AL. Finding the perfect doctor: identifying lesbian, gay, bisexual, and transgender-competent physicians. Am J Public Health. 2015;105(6):1114–9.
World Health Organization. Key considerations for differentiated antiretroviral therapy delivery for specific populations: children, adolescents, pregnant and breastfeeding women and key populations. Published 2017. Geneva, Switzerland. https://apps.who.int/iris/bitstream/handle/10665/258506/WHO-HIV-2017.34-eng.pdf;jsessionid=8111D80C277E16B175B3DB150AD6AD72?sequence=1.
Centers for Disease Control and Prevention. Recommendations for HIV prevention with adults and adolescents with HIV in the United States, 2014. Centers for Disease Control and Prevention, Health Resources and Services Administration, National Institutes of Health, American Academy of HIV Medicine, Association of Nurses in AIDS Care, International Association of Providers of AIDS Care, the National Minority AIDS Council, and Urban Coalition for HIV/AIDS Prevention Services. 2014.
Hall HI, Song R, Tang T, et al. HIV trends in the United States: diagnoses and estimated incidence. JMIR Public Health Surveill. 2017;3(1):e8.
Kangovi S, Mitra N, Grande D, Huo H, Smith RA, Long JA. Community health worker support for disadvantaged patients with multiple chronic diseases: a randomized clinical trial. Am J Public Health. 2017;107(10):1660–7.
Ramchand R, Ahluwalia SC, Xenakis L, Apaydin E, Raaen L, Grimm G. A systematic review of peer-supported interventions for health promotion and disease prevention. Prev Med. 2017;101:156–70.
Bateganya MH, Amanyeiwe U, Roxo U, Dong M. Impact of support groups for people living with HIV on clinical outcomes: a systematic review of the literature. J Acquir Immune Defic Syndr. 2015;68(Suppl 3):S368–S374374.
Amico KR. Evidence for technology interventions to promote ART adherence in adult populations: a review of the literature 2012–2015. Curr HIV/AIDS Rep. 2015;12(4):441–50.
Gaysynsky A, Romansky-Poulin K, Arpadi S. "My YAP Family": analysis of a Facebook Group for young adults living with HIV. AIDS Behav. 2015;19(6):947–62.
Simoni JM, Ronen K, Aunon FM. Health behavior theory to enhance eHealth intervention research in HIV: rationale and review. Curr HIV/AIDS Rep. 2018;15(6):423–30.
Fuchs JD, Stojanovski K, Vittinghoff E, et al. A mobile health strategy to support adherence to antiretroviral preexposure prophylaxis. AIDS Pat Care STDS. 2018;32(3):104–11.
Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376(9755):1838–45.
Moore DJ, Jain S, Dube MP, et al. Randomized controlled trial of daily text messages to support adherence to preexposure prophylaxis in individuals at risk for human immunodeficiency virus: the TAPIR Study. Clin Infect Dis. 2018;66(10):1566–72.
Centers for Disease Control and Prevention. Effective interventions: HIV prevention that works. https://effectiveinterventions.cdc.gov. Accessed 21 Aug 2019.
Garcia J, Colson PW, Parker C, Hirsch JS. Passing the baton: Community-based ethnography to design a randomized clinical trial on the effectiveness of oral pre-exposure prophylaxis for HIV prevention among Black men who have sex with men. Contemp Clin Trials. 2015;45(Pt B):244–51.
Wilson IB, Lee Y, Michaud J, Fowler FJ Jr, Rogers WH. Validation of a new three-item self-report measure for medication adherence. AIDS Behav. 2016;20(11):2700–8.
Anderson PL, Liu AY, Castillo-Mancilla JR, et al. Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy. Antimicrob Agents Chemother. 2018;62(1):e01710.
Chan PA, Mena L, Patel R, et al. Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. J Int AIDS Soc. 2016;19(1):20903.
Colson PW, Hirsch-Moverman Y, Franks J, Ortega H, El-Sadr WM. PrEP knowledge & attitudes, perceived benefits and barriers. Columbia: ICAP, Columbia University; 2014.
Simpson DD, Joe GW, Knight K, Rowan-Szal GA, Gray JS. Texas Christian University (TCU) short forms for assessing client needs and functioning in addiction treatment. J Offender Rehabil. 2012;51(1–2):34–56.
Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction. 1993;88(6):791–804.
Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.
Pass HJ. PASS 2008. Utah: NCSS, LLC; 2008.
Garcia J, Parker C, Parker RG, Wilson PA, Philbin M, Hirsch JS. Psychosocial implications of homophobia and HIV stigma in social support networks: insights for high-impact HIV prevention among black men who have sex with men. Health Educ Behav. 2016;43(2):217–25.
Garcia J, Parker C, Parker RG, Wilson PA, Philbin MM, Hirsch JS. "You're really gonna kick us all out?" Sustaining safe spaces for community-based HIV prevention and control among black men who have sex with men. PLoS ONE. 2015;10(10):e0141326.
Parker CM, Parker RG, Philbin MM, Hirsch JS. The impact of urban US policing practices on black men who have sex with men's HIV vulnerability: ethnographic findings and a conceptual model for future research. J Urban Health. 2018;95(2):171–8.
Alsabbagh MH, Lemstra M, Eurich D, et al. Socioeconomic status and nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Value Health. 2014;17(2):288–96.
Falagas ME, Zarkadoulia EA, Pliatsika PA, Panos G. Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature. Retrovirology. 2008;5:13.
Marcus JL, Hurley LB, Hare CB, et al. Preexposure prophylaxis for HIV prevention in a large integrated health care system: adherence, renal safety, and discontinuation. J Acquir Immune Defic Syndr. 2016;73(5):540–6.
Hosek SG, Rudy B, Landovitz R, et al. An HIV preexposure prophylaxis demonstration project and safety study for young MSM. J Acquir Immune Defic Syndr. 2017;74(1):21–9.
Kaaya S, Eustache E, Lapidos-Salaiz I, Musisi S, Psaros C, Wissow L. Grand challenges: improving HIV treatment outcomes by integrating interventions for co-morbid mental illness. PLoS Med. 2013;10(5):e1001447.
Patel V, Belkin GS, Chockalingam A, Cooper J, Saxena S, Unutzer J. Grand challenges: integrating mental health services into priority health care platforms. PLoS Med. 2013;10(5):e1001448.
Golub SA, Pena S, Hilley A, Pachankis J, Radix A. Brief behavioral intervention increases PrEP drug levels in a real-world setting. Conference on retroviruses and opportunistic infections; Seattle, WA. abs 965. 2017.
Wheeler DP, Fields SD, Beauchamp G, et al. Pre-exposure prophylaxis initiation and adherence among Black men who have sex with men (MSM) in three US cities: results from the HPTN 073 study. J Int AIDS Soc. 2019;22(2):e25223.
Remy L, Enriquez M. Behavioral interventions to enhance PrEP uptake among black men who have sex with men: a review. J Assoc Nurses AIDS Care. 2019;30(2):151–63.
Daughtridge GW, Conyngham SC, Ramirez N, Koenig HC. I am men's health: generating adherence to HIV pre-exposure prophylaxis (PrEP) in young men of color who have sex with men. J Int Assoc Provid AIDS Care. 2015;14(2):103–7.
Rao WW, Yang MJ, Cao BN, et al. Psychological distress in cancer patients in a large Chinese cross-sectional study. J Affect Disord. 2019;245:950–6.
Ronel J, Dinkel A, Wolf E, et al. Anxiety, depression, and health-related quality of life in aging people living with HIV compared to diabetes patients and patients with minor health conditions: a longitudinal study. Psychol Health Med. 2018;23(7):823–30.
Fields E, Morgan A, Sanders RA. The intersection of sociocultural factors and health-related behavior in Lesbian, Gay, bisexual, and transgender youth: experiences among young black gay males as an example. Pediatr Clin N Am. 2016;63(6):1091–106.
Wilson PA, Meyer IH, Antebi-Gruszka N, Boone MR, Cook SH, Cherenack EM. Profiles of resilience and psychosocial outcomes among young black gay and bisexual men. Am J Commun Psychol. 2016;57(1–2):144–57.
Lane SD, Rubinstein RA, Bergen-Cico D, et al. Neighborhood trauma due to violence: a multilevel analysis. J Health Care Poor Underserved. 2017;28(1):446–62.
Meyer IH, Northridge ME. The health of sexual minorities: public health perspectives on lesbian, gay, bisexual and transgender populations. New York: Springer; 2007.
Mustanski B, Garofalo R, Herrick A, Donenberg G. Psychosocial health problems increase risk for HIV among urban young men who have sex with men: preliminary evidence of a syndemic in need of attention. Ann Behav Med. 2007;34(1):37–45.
Stall R, Mills TC, Williamson J, et al. Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. Am J Public Health. 2003;93(6):939–42.
Young LE, Schumm P, Alon L, et al. PrEP Chicago: a randomized controlled peer change agent intervention to promote the adoption of pre-exposure prophylaxis for HIV prevention among young Black men who have sex with men. Clin Trials. 2018;15(1):44–52.
Duncan DT, Hickson DA, Goedel WC, et al. The social context of HIV prevention and care among black men who have sex with men in three U.S. Cities: the neighborhoods and networks (N2) cohort study. Int J Environ Res Public Health. 2019;16(11):1922.
Phillips G 2nd, Neray B, Birkett M, Felt D, Janulis P, Mustanski B. Role of social and sexual network factors in PrEP utilization among YMSM and transgender women in Chicago. Prev Sci. 2019;20(7):1089–97.
Haberer JE, Kidoguchi L, Heffron R, et al. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence. J Int AIDS Soc. 2017;20(1):21842.
Baeten J, Palanee-Phillips T, Mgodi N, et al. High uptake and reduced HIV-1 incidence in an open-lable trial of the dapivirine ring. Conference on Retroviruses and Opportunistic Infections; Bsoton, MA. abs 143LB. 2018.
Derby N, Lal M, Aravantinou M, et al. Griffithsin/Carrageenan inserts prevent SHIV, HSV-2, and HPV infections in vivo. Conference on Retroviruses and Opportunistic Infections; Boston, MA. abs 84. 2018.
Myers JE, Sepkowitz KA. A pill for HIV prevention: deja vu all over again? Clin Infect Dis. 2013;56(11):1604–12.
Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995;Spec No:80–94.
Rael CT, Martinez M, Giguere R, et al. Barriers and facilitators to oral PrEP use among transgender women in New York City. AIDS Behav. 2018;22(11):3627–36.
Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among black and white men and transgender women who have sex with men. AIDS Behav. 2017;21(5):1236–46.
Mustanski B, Ryan DT, Hayford C, Phillips G 2nd, Newcomb ME, Smith JD. Geographic and individual associations with PrEP stigma: results from the RADAR cohort of diverse young men who have sex with men and transgender women. AIDS Behav. 2018;22(9):3044–56.
Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr. 2010;54(5):548–55.